Certara, Inc. (NASDAQ:CERT) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. reduced its stake in shares of Certara, Inc. (NASDAQ:CERTFree Report) by 39.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,467 shares of the company’s stock after selling 4,205 shares during the period. PNC Financial Services Group Inc.’s holdings in Certara were worth $114,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of CERT. Pineridge Advisors LLC acquired a new position in shares of Certara during the 4th quarter worth approximately $28,000. Natixis Advisors L.P. raised its position in shares of Certara by 13.4% during the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock worth $220,000 after purchasing an additional 1,791 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Certara by 1,704.0% during the 4th quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock worth $224,000 after purchasing an additional 12,047 shares during the last quarter. Truist Financial Corp raised its position in shares of Certara by 20.5% during the 4th quarter. Truist Financial Corp now owns 13,958 shares of the company’s stock worth $246,000 after purchasing an additional 2,372 shares during the last quarter. Finally, Premier Fund Managers Ltd raised its position in shares of Certara by 87.5% during the 4th quarter. Premier Fund Managers Ltd now owns 16,553 shares of the company’s stock worth $296,000 after purchasing an additional 7,727 shares during the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CERT has been the subject of several analyst reports. Barclays cut their price target on Certara from $18.00 to $16.00 and set an “equal weight” rating for the company in a report on Friday, June 28th. JMP Securities initiated coverage on Certara in a report on Thursday, April 4th. They issued a “market perform” rating for the company. Finally, KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price target for the company in a report on Wednesday, April 10th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Certara has a consensus rating of “Hold” and an average target price of $19.81.

Read Our Latest Report on CERT

Certara Trading Up 2.7 %

CERT stock opened at $14.22 on Friday. The company has a market cap of $2.29 billion, a price-to-earnings ratio of -36.46, a PEG ratio of 4.65 and a beta of 1.52. The company has a quick ratio of 3.26, a current ratio of 3.26 and a debt-to-equity ratio of 0.27. The business has a fifty day simple moving average of $15.77 and a 200-day simple moving average of $16.77. Certara, Inc. has a 52 week low of $11.81 and a 52 week high of $19.87.

Certara (NASDAQ:CERTGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). The firm had revenue of $96.65 million for the quarter, compared to analyst estimates of $94.48 million. Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. On average, equities research analysts expect that Certara, Inc. will post 0.29 EPS for the current year.

Certara Profile

(Free Report)

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Featured Stories

Institutional Ownership by Quarter for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.